MedPath

This study is to standardise the treatment for Parkinsons disease a neurological disorder in a single group study

Not Applicable
Conditions
Health Condition 1: null- Parkinsons disease
Registration Number
CTRI/2018/08/015296
Lead Sponsor
Rajiv Gandhi University Of Health Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients exhibiting the features of Kampavata like Kharapadatalakampa,Dehabhramana,Nidrabhanga and Matiksheena.(PD) Viz Tremors,Regidity,bradikinesia and postural imbalance.

2 Patients of either sex between the age group of 40-80yrs.

3 Already diagnosed cases will be Included.

Exclusion Criteria

1.Patients with other systemic disorders and with other complications which interfere with the treatment has be excluded from the study also the subjecte presented with following conditions will be excluded ,

2.History of repeated strokes with stepwise progression of Parkinsonâ??s disease.

3.History of head injury.

4.History of definite encephalitis.

5.Strictly unilateral features after 3 years.

6.Early severe dementia with disturbance of memory and language.

7.History of IBS ,History of Drug Sensitivity will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Kapikacchu contains Levodopa which will act as best neuroprotective in Kampavata,parkinsons disease.Varuni taila mentioned in kampavata by Sharangadhara will help in curing Kapha avrita vyana vata in Kampavata,Parkinsons diasease.Matra basti with Sahacharadi taila,bsti holds good for Vata vyadhis.Timepoint: 48 days
Secondary Outcome Measures
NameTimeMethod
it form best remedy for Kampavata, Parkinsons diseaseTimepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath